Search Results - "Krom, Yvonne D"

Refine Results
  1. 1
  2. 2

    DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis by Knopp, Paul, Krom, Yvonne D, Banerji, Christopher R S, Panamarova, Maryna, Moyle, Louise A, den Hamer, Bianca, van der Maarel, Silvère M, Zammit, Peter S

    Published in Journal of cell science (15-10-2016)
    “…Skeletal muscle wasting in facioscapulohumeral muscular dystrophy (FSHD) results in substantial morbidity. On a disease-permissive chromosome 4qA haplotype,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    PABPN1-Dependent mRNA Processing Induces Muscle Wasting by Riaz, Muhammad, Raz, Yotam, van Putten, Maaike, Paniagua-Soriano, Guillem, Krom, Yvonne D, Florea, Bogdan I, Raz, Vered

    Published in PLoS genetics (06-05-2016)
    “…Poly(A) Binding Protein Nuclear 1 (PABPN1) is a multifunctional regulator of mRNA processing, and its expression levels specifically decline in aging muscles…”
    Get full text
    Journal Article
  7. 7

    Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice by Bouwman, Linde F, den Hamer, Bianca, Verveer, Elwin P, Lerink, Lente J S, Krom, Yvonne D, van der Maarel, Silvère M, de Greef, Jessica C

    Published in Skeletal muscle (01-10-2020)
    “…Facioscapulohumeral muscular dystrophy (FSHD) is a skeletal muscle disorder that is caused by derepression of the transcription factor DUX4 in skeletal muscle…”
    Get full text
    Journal Article
  8. 8

    Occurrence of symptoms in different stages of Duchenne muscular dystrophy and their impact on social participation by Houwen‐van Opstal, Saskia L. S., Heutinck, Lotte, Jansen, Merel, Krom, Yvonne D., Cup, Edith H. C., Hendriksen, Jos G. M., Willemsen, Michel A. A. P., Verschuuren, Jan J. G. M., Niks, Erik H., Groot, Imelda J. M.

    Published in Muscle & nerve (01-12-2021)
    “…Introduction/Aims As life expectancy improves for patients with Duchenne muscular dystrophy (DMD), new symptoms are likely to arise. This aims of this study…”
    Get full text
    Journal Article
  9. 9

    Smchd1 haploinsufficiency exacerbates the phenotype of a transgenic FSHD1 mouse model by de Greef, Jessica C, Krom, Yvonne D, den Hamer, Bianca, Snider, Lauren, Hiramuki, Yosuke, van den Akker, Rob F P, Breslin, Kelsey, Pakusch, Miha, Salvatori, Daniela C F, Slütter, Bram, Tawil, Rabi, Blewitt, Marnie E, Tapscott, Stephen J, van der Maarel, Silvère M

    Published in Human molecular genetics (15-02-2018)
    “…Abstract In humans, a copy of the DUX4 retrogene is located in each unit of the D4Z4 macrosatellite repeat that normally comprises 8–100 units. The D4Z4 repeat…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    The Dilemma of Choice for Duchenne Patients Eligible for Exon 51 Skipping The European Experience by Aartsma-Rus, Annemieke, De Waele, Liesbeth, Houwen-Opstal, Saskia, Kirschner, Janbernd, Krom, Yvonne D, Mercuri, Eugenio, Niks, Erik H, Straub, Volker, van Duyvenvoorde, Hermine A, Vroom, Elizabeth

    Published in Journal of neuromuscular diseases (01-01-2023)
    “…Antisense oligonucleotide (ASO) mediated exon skipping aims to reframe dystrophin transcripts for patients with Duchenne muscular dystrophy (DMD). Currently 4…”
    Get more information
    Journal Article
  14. 14

    Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients by Catapano, Francesco, Domingos, Joana, Perry, Mark, Ricotti, Valeria, Phillips, Lauren, Servais, Laurent, Seferian, Andreea, Groot, Imelda de, Krom, Yvonne D, Niks, Erik H, Verschuuren, Jan JGM, Straub, Volker, Voit, Thomas, Morgan, Jennifer, Muntoni, Francesco

    Published in Epigenomics (01-07-2018)
    “…To study the signature of 87 urinary miRNAs in Duchenne muscular dystrophy (DMD) patients, select the most dysregulated and determine statistically significant…”
    Get full text
    Journal Article Web Resource
  15. 15
  16. 16

    Differential myofiber-type transduction preference of adeno-associated virus serotypes 6 and 9 by Riaz, Muhammad, Raz, Yotam, Moloney, Elizabeth B, van Putten, Maaike, Krom, Yvonne D, van der Maarel, Silvere M, Verhaagen, Joost, Raz, Vered

    Published in Skeletal muscle (10-11-2015)
    “…Gene therapy strategies are promising therapeutic options for monogenic muscular dystrophies, with several currently underways. The adeno-associated viral…”
    Get full text
    Journal Article
  17. 17

    Efficient in vivo knock-down of estrogen receptor alpha: application of recombinant adenovirus vectors for delivery of short hairpin RNA by Krom, Yvonne D, Fallaux, Frits J, Que, Ivo, Lowik, Clemens, van Dijk, Ko Willems

    Published in BMC biotechnology (28-02-2006)
    “…Adenovirus (Ad) mediated gene transfer is a well-established tool to transiently express constructs in livers of mice in vivo. In the present study, we…”
    Get full text
    Journal Article
  18. 18

    Compliance to DMD Care Considerations in the Netherlands by Heutinck, Lotte, Houwen-van Opstal, Saskia L S, Krom, Yvonne D, Niks, Erik H, Verschuuren, Jan J G M, Jansen, Merel, de Groot, Imelda J M

    Published in Journal of neuromuscular diseases (01-01-2021)
    “…To optimize care for patients with DMD, it is essential to know to what extent current care complies with the recommended monitoring frequencies suggested by…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists by KROM, Yvonne D, PIRES, Nuno M. M, WOUTER JUKEMA, J, DE VRIES, Margreet R, FRANTS, Rune R, HAVEKES, Louis M, VAN DIJK, Ko Willems, QUAX, Paul H. A

    Published in Cardiovascular research (2007)
    “…Neointima formation is the underlying mechanism of (in-stent) restenosis. 17beta-Estradiol (E2) is known to inhibit injury-induced neointima formation and…”
    Get full text
    Journal Article